• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年龄、体重指数和血尿素氮联合作为预测 COVID-19 患者氧需求的预后因素的有用性。

The usefulness of a combination of age, body mass index, and blood urea nitrogen as prognostic factors in predicting oxygen requirements in patients with coronavirus disease 2019.

机构信息

First Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Nagano, 390-8621, Japan.

First Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Nagano, 390-8621, Japan.

出版信息

J Infect Chemother. 2021 Dec;27(12):1706-1712. doi: 10.1016/j.jiac.2021.08.009. Epub 2021 Aug 13.

DOI:10.1016/j.jiac.2021.08.009
PMID:34412984
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8360991/
Abstract

INTRODUCTION

Risk factors for seriously ill coronavirus disease 19 (COVID-19) patients have been reported in several studies. However, to date, few studies have reported simple risk assessment tools for distinguishing patients becoming severely ill after initial diagnosis. Hence, this study aimed to develop a simple clinical risk nomogram predicting oxygenation risk in patients with COVID-19 at the first triage.

METHODS

This retrospective study involved a chart review of the medical records of 84 patients diagnosed with COVID-19 between February 2020 and March 2021 at ten medical facilities. The patients were divided into requiring no oxygen therapy (non-severe group) and requiring oxygen therapy (severe group). Patient characteristics were compared between the two groups. We utilized univariate logistic regression analysis to confirm determinants of high risks of requiring oxygen therapy in patients with moderate COVID-19.

RESULTS

Thirty-five patients ware in severe group and forty-nine patients were in non-severe group. In comparison with patients in the non-severe group, patients in the severe group were significantly older with higher body mass index (BMI), and had a history of hypertension and diabetes. Serum blood urea nitrogen (BUN), lactic acid dehydrogenase (LDH), and C-reactive protein (CRP) levels were significantly higher in the severe group. Multivariate analysis showed that older age, higher BMI, and higher BUN levels were significantly associated with oxygen requirements.

CONCLUSIONS

This study demonstrated that age, BMI, and BUN were independent risk factors in the moderate-to-severe COVID-19 group. Elderly patients with higher BMI and BUN require close monitoring and early treatment initiation.

摘要

简介

几项研究报告了导致严重的 2019 冠状病毒病(COVID-19)患者患病的风险因素。然而,迄今为止,很少有研究报告简单的风险评估工具来区分初始诊断后病情严重的患者。因此,本研究旨在开发一种简单的临床风险列线图,以预测 COVID-19 患者首次分诊时的氧合风险。

方法

本回顾性研究纳入了 2020 年 2 月至 2021 年 3 月期间在十个医疗机构诊断为 COVID-19 的 84 例患者的病历回顾。患者分为无需氧疗(非重症组)和需要氧疗(重症组)。比较两组患者的特征。我们利用单因素 logistic 回归分析确认中度 COVID-19 患者需要氧疗的高风险的决定因素。

结果

35 例患者为重症组,49 例患者为非重症组。与非重症组患者相比,重症组患者年龄较大,体重指数(BMI)较高,且有高血压和糖尿病病史。重症组患者的血清血尿素氮(BUN)、乳酸脱氢酶(LDH)和 C 反应蛋白(CRP)水平明显较高。多因素分析显示,年龄较大、BMI 较高和 BUN 水平较高与氧需求显著相关。

结论

本研究表明,年龄、BMI 和 BUN 是 COVID-19 中重度患者的独立危险因素。年龄较大、BMI 较高和 BUN 较高的老年患者需要密切监测和早期治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4c3/8360991/f6c1a2e10ae4/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4c3/8360991/5752d1ce9e45/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4c3/8360991/f6c1a2e10ae4/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4c3/8360991/5752d1ce9e45/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4c3/8360991/f6c1a2e10ae4/gr2_lrg.jpg

相似文献

1
The usefulness of a combination of age, body mass index, and blood urea nitrogen as prognostic factors in predicting oxygen requirements in patients with coronavirus disease 2019.年龄、体重指数和血尿素氮联合作为预测 COVID-19 患者氧需求的预后因素的有用性。
J Infect Chemother. 2021 Dec;27(12):1706-1712. doi: 10.1016/j.jiac.2021.08.009. Epub 2021 Aug 13.
2
Predictive role of clinical features in patients with coronavirus disease 2019 for severe disease.2019冠状病毒病患者临床特征对重症疾病的预测作用
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2020 May 28;45(5):536-541. doi: 10.11817/j.issn.1672-7347.2020.200384.
3
Characteristics of laboratory findings of COVID-19 patients with comorbid diabetes mellitus.伴有糖尿病的 COVID-19 患者的实验室检查结果特征。
Diabetes Res Clin Pract. 2020 Sep;167:108351. doi: 10.1016/j.diabres.2020.108351. Epub 2020 Jul 22.
4
New York Inner City Hospital COVID-19 Experience and Current Data: Retrospective Analysis at the Epicenter of the American Coronavirus Outbreak.纽约市中心医院新冠肺炎的经历与当前数据:美国新冠疫情中心的回顾性分析
J Med Internet Res. 2020 Sep 18;22(9):e20548. doi: 10.2196/20548.
5
[Clinical characteristics and risk factors of acute kidney injury in coronavirus disease 2019].2019冠状病毒病急性肾损伤的临床特征及危险因素
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Apr;32(4):407-411. doi: 10.3760/cma.j.cn121430-20200302-00198.
6
Association between obesity and clinical prognosis in patients infected with SARS-CoV-2.肥胖与 SARS-CoV-2 感染患者临床预后的关系。
Infect Dis Poverty. 2020 Jun 29;9(1):80. doi: 10.1186/s40249-020-00703-5.
7
A simple nomogram for predicting failure of non-invasive respiratory strategies in adults with COVID-19: a retrospective multicentre study.用于预测 COVID-19 成人无创呼吸策略失败的简易列线图:一项回顾性多中心研究。
Lancet Digit Health. 2021 Mar;3(3):e166-e174. doi: 10.1016/S2589-7500(20)30316-2. Epub 2021 Feb 8.
8
A Tool for Early Prediction of Severe Coronavirus Disease 2019 (COVID-19): A Multicenter Study Using the Risk Nomogram in Wuhan and Guangdong, China.一种用于早期预测严重 2019 冠状病毒病(COVID-19)的工具:来自中国武汉和广东的多中心研究使用风险列线图。
Clin Infect Dis. 2020 Jul 28;71(15):833-840. doi: 10.1093/cid/ciaa443.
9
Clinical characteristics and the risk factors for severe events of elderly coronavirus disease 2019 patients.2019年冠状病毒病老年患者的临床特征及严重事件的危险因素
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2020 May 28;45(5):542-548. doi: 10.11817/j.issn.1672-7347.2020.200292.
10
Obesity, glucose intolerance, advanced age, and lymphocytopenia are independent risk factors for oxygen requirement in Japanese patients with Coronavirus disease 2019 (COVID-19).肥胖、葡萄糖耐量异常、高龄和淋巴细胞减少是日本 2019 冠状病毒病(COVID-19)患者需要吸氧的独立危险因素。
Endocr J. 2021 Jul 28;68(7):849-856. doi: 10.1507/endocrj.EJ20-0784. Epub 2021 Mar 24.

引用本文的文献

1
A Nomogram for Predicting Survival in Patients with Respiratory Failure Following Trauma: A Retrospective Study Using the MIMIC-IV Database.一种用于预测创伤后呼吸衰竭患者生存率的列线图:一项使用MIMIC-IV数据库的回顾性研究
Drug Healthc Patient Saf. 2025 Mar 5;17:63-74. doi: 10.2147/DHPS.S497413. eCollection 2025.
2
Clinical and epidemiological risk factors associated with hospitalization and mortality rate of COVID-19 patients in Banja Luka County: A retrospective observational cohort study on 40,000 patients.巴尼亚卢卡县新冠肺炎患者住院及死亡率相关的临床和流行病学危险因素:一项对40000名患者的回顾性观察队列研究
J Family Med Prim Care. 2024 May;13(5):2130-2137. doi: 10.4103/jfmpc.jfmpc_1641_23. Epub 2024 May 24.
3

本文引用的文献

1
Obesity in COVID-19 era, implications for mechanisms, comorbidities, and prognosis: a review and meta-analysis.在新冠疫情时代的肥胖症:对发病机制、合并症和预后的影响:综述和荟萃分析。
Int J Obes (Lond). 2021 May;45(5):998-1016. doi: 10.1038/s41366-021-00776-8. Epub 2021 Feb 26.
2
Obesity Increases the Severity and Mortality of Influenza and COVID-19: A Systematic Review and Meta-Analysis.肥胖增加了流感和 COVID-19 的严重程度和死亡率:系统评价和荟萃分析。
Front Endocrinol (Lausanne). 2020 Dec 21;11:595109. doi: 10.3389/fendo.2020.595109. eCollection 2020.
3
Risk Factors Associated With In-Hospital Mortality in a US National Sample of Patients With COVID-19.
Serum lipid mediator profiles in COVID-19 patients and lung disease severity: a pilot study.
COVID-19 患者血清脂质介质谱与肺部疾病严重程度:一项初步研究。
Sci Rep. 2023 Apr 20;13(1):6497. doi: 10.1038/s41598-023-33682-2.
4
Development and Validation of a Predictive Nomogram with Age and Laboratory Findings for Severe COVID-19 in Hunan Province, China.基于年龄和实验室检查结果的湖南省重症新型冠状病毒肺炎预测列线图的开发与验证
Ther Clin Risk Manag. 2022 May 17;18:579-591. doi: 10.2147/TCRM.S361936. eCollection 2022.
与美国 COVID-19 患者住院死亡率相关的风险因素。
JAMA Netw Open. 2020 Dec 1;3(12):e2029058. doi: 10.1001/jamanetworkopen.2020.29058.
4
Risk Factors for COVID-19.新型冠状病毒肺炎的风险因素。
Infez Med. 2020 Dec 1;28(4):469-474.
5
Risk factors for severe and critically ill COVID-19 patients: A review.COVID-19 患者重症和危重症的危险因素:综述。
Allergy. 2021 Feb;76(2):428-455. doi: 10.1111/all.14657. Epub 2020 Dec 4.
6
Predictive performance of SOFA and qSOFA for in-hospital mortality in severe novel coronavirus disease.序贯器官衰竭评估(SOFA)和简化序贯器官衰竭评估(qSOFA)对严重新型冠状病毒病住院患者死亡率的预测性能。
Am J Emerg Med. 2020 Oct;38(10):2074-2080. doi: 10.1016/j.ajem.2020.07.019. Epub 2020 Jul 12.
7
Aging in COVID-19: Vulnerability, immunity and intervention.COVID-19 相关衰老问题:脆弱性、免疫与干预。
Ageing Res Rev. 2021 Jan;65:101205. doi: 10.1016/j.arr.2020.101205. Epub 2020 Oct 31.
8
Non-respiratory presentations of COVID-19, a clinical review.COVID-19 的非呼吸系统表现:临床综述
Am J Emerg Med. 2020 Nov;38(11):2444-2454. doi: 10.1016/j.ajem.2020.09.054. Epub 2020 Sep 24.
9
Development and Validation of the Quick COVID-19 Severity Index: A Prognostic Tool for Early Clinical Decompensation.快速 COVID-19 严重程度指数的制定与验证:一种用于早期临床失代偿的预后工具。
Ann Emerg Med. 2020 Oct;76(4):442-453. doi: 10.1016/j.annemergmed.2020.07.022. Epub 2020 Jul 21.
10
Association of body mass index (BMI) with critical COVID-19 and in-hospital mortality: A dose-response meta-analysis.体重指数(BMI)与重症 COVID-19 和住院死亡率的关系:剂量反应荟萃分析。
Metabolism. 2021 Apr;117:154373. doi: 10.1016/j.metabol.2020.154373. Epub 2020 Sep 16.